BUSINESS● LOWJun 29 · Jun 29, 2026, 9:10 AM
Ipsen to buy Kartos Therapeutics for $450M to boost oncology pipeline
Seeking Alpha Tech
Ipsen plans to acquire Kartos Therapeutics for $450 million, aiming to enhance its oncology drug development pipeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS35m agoMeta's AI build is Muse-ic to investors' earsSeeking Alpha TechBUSINESS36m agoMETA on track for its third consecutive drop of more than 5% after earningsSeeking Alpha Tech